Summary & Overview

CPT 84600: Volatile Compound Analysis in Blood or Urine

CPT code 84600 represents a laboratory assay for the detection and quantification of volatile compounds in blood or urine, commonly performed using gas chromatography. This analytic test is used in clinical toxicology to identify exposures to volatile chemicals and to support diagnosis and treatment decisions in acute and chronic settings. Nationally, accurate coding for such specialized laboratory procedures supports appropriate clinical interpretation, billing compliance, and laboratory quality reporting.

Key payers discussed include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context and the laboratory setting for this test, common payer coverage considerations, and benchmarking topics relevant to specialized toxicology assays. The publication summarizes coding specifics for billing workflows, typical sites of service, and the clinical scenarios where volatile compound testing is applied. It also highlights areas where payers and providers commonly align or differ on coverage and documentation expectations.

This summary orients laboratory managers, medical coders, compliance officers, and clinical leaders to the operational and policy implications of CPT code 84600, providing practical context for coding, reimbursement inquiries, and integration into laboratory service portfolios.

AetnaBlue Cross Blue ShieldCigna HealthUnitedHealthcareMedicare84600CPTlaboratorytoxicologygas-chromatographyvolatile-compoundsclinical-lablaboratory-coding

Billing Code Overview

CPT code 84600 describes a laboratory test that measures volatile compounds in blood and/or urine, such as acetic anhydride or diethyl ether, typically performed using gas chromatography. This service is a clinical toxicology/analytical chemistry assay used to detect and quantify volatile substances that may indicate exposure, intoxication, or metabolic processes.

Service type: Laboratory analytical test (gas chromatography-based volatile analysis)
Typical site of service: Clinical laboratory or hospital laboratory; specimen collection may occur in inpatient, outpatient, or emergency settings

Data not available in the input for associated taxonomies, ICD-10 codes, or related codes.

Clinical & Coding Specifications

Clinical Context

A typical patient is a 28-year-old male brought to the emergency department after a motor vehicle collision with altered mental status and odor of volatile substances. The treating clinician orders volatile substance testing on blood and urine to detect exposure to substances such as ethyl ether, acetic anhydride, or other volatile solvents. A phlebotomy technician collects blood and a urine specimen; both specimens are labeled and sent to the hospital or reference laboratory. A clinical laboratory analyst performs quantitative analysis using gas chromatography (GC) or gas chromatography–mass spectrometry (GC-MS) to identify and measure volatile compounds. Results are reported to the ordering provider and added to the medical record to support emergency management, toxicology consultation, legal documentation, or occupational exposure evaluation. Typical sites of service include hospital emergency departments, inpatient hospital laboratories, outpatient hospital laboratory draw stations, and independent clinical reference laboratories.

Coding Specifications

Modifier	Description	When to Use
`26`	Professional component	When billing separates the laboratory professional interpretation from the technical component (rare for high-complexity toxicology but used if applicable).
`59`	Distinct procedural service	When the volatile analysis is a distinct lab service performed separate from other billed lab tests on the same date.
`90`	Reference (Outside) laboratory	When testing is performed by an outside/reference laboratory and not by the submitting laboratory.
`91`	Repeat clinical diagnostic laboratory test	When a repeat volatile measurement is performed on the same specimen to confirm results.
`52`	Reduced services	When the laboratory performs a reduced-scope analysis compared to the full testing protocol.
`53`	Discontinued procedure	When specimen testing is started but discontinued prior to completion (rare administrative use).
`78`	Unanticipated return to the operating/procedure room	If peri-procedural surgical exposure requires repeat toxicology testing during the same operative episode (infrequent).
`80`	Assistant surgeon	If a surgical assistant’s involvement affects ancillary testing documentation (rare relevance).
`91`	Repeat test (listed above)	See prior entry; used for reportable repeat confirmations.
`QX`	Service furnished under a primary lab director's CLIA number by a CLIA-certified independent practitioner	When a qualified practitioner furnishes the analytic service under a delegated arrangement.

Taxonomy Code	Specialty	Notes
207RH0000X	Anatomic and Clinical Pathology	Clinical laboratory directors and pathologists who oversee toxicology testing.
207L00000X	Clinical Laboratory	Medical technologists and laboratory medicine specialists performing GC/GC-MS testing.
2080P0206X	Emergency Medicine	Emergency physicians who order and interpret volatile substance testing in acute exposure.
363LA2200X	Toxicology	Clinical toxicologists or poison center consultants who interpret complex volatile results.
208D00000X	Medical Toxicology	Specialists consulted for management based on volatile compound levels.

Related Diagnoses

ICD-10 Code	Description	Clinical Relevance
`T51.0X1A`	Toxic effect of ethanol, accidental (initial encounter)	Volatile alcohol exposure is a common reason to measure volatiles in blood/urine in acute intoxication.
`T51.0X2A`	Toxic effect of ethanol, intentional self-harm (initial encounter)	Testing used in intentional ingestion/poisoning evaluations.
`T51.1X1A`	Toxic effect of methanol, accidental (initial encounter)	Methanol is a toxic volatile alcohol requiring chromatographic measurement for diagnosis and management.
`T51.2X1A`	Toxic effect of isopropyl alcohol, accidental (initial encounter)	Isopropanol exposure is detected via volatile analysis to guide care.
`F10.129`	Alcohol abuse with intoxication, uncomplicated	Clinical context where volatile ethanol measurement may be indicated.
`R78.89`	Finding of other substances, not elsewhere classified	Used when laboratory detects volatile or solvent compounds not covered by specific codes.
`T59.9X1A`	Toxic effect of nonmedicinal substance, unspecified, accidental (initial encounter)	Broad code for acute toxic exposures when specific agent is pending laboratory confirmation.
`Z03.89`	Encounter for observation for other suspected diseases and conditions ruled out	Used when volatile testing is part of an exposure workup that subsequently rules out significant toxic effect.

Related CPT Codes

CPT Code	Description	Relationship to This Procedure
`80307`	Drug test, definitive, any method, qualitative or quantitative, multiple drug classes; e.g., confirmation by chromatography	Commonly performed alongside or as confirmatory testing for specific drugs when volatile exposure is suspected.
`80306`	Drug test, definitive, each procedure, includes chromatographic confirmation	Used for definitive identification of specific non-volatile drugs when a comprehensive toxicology panel is ordered in conjunction.
`82043`	Assay of bilirubin; quantitative (example of laboratory analytic CPT for small-molecule analytes)	Represents comparable laboratory analytic coding practice; labs may bill appropriate analytic CPTs depending on payer guidance.
`G0480`	Drug tests, definitive, all testing technologies, performed using multiple-step methods, per day, up to 7 results	May apply in certain Medicare or payer policies for bundled definitive testing panels that include volatile analytes.
`99000`	Handling and/or conveyance of specimen for transport; When special handling/transport is required for volatile specimen stability	Billed when special courier/handling is needed to preserve volatile analytes during transport to the reference laboratory.